Cargando…

Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes

CONTEXT: South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. OBJECTIVE: This work aimed to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Straat, Maaike E, Martinez-Tellez, Borja, van Eyk, Huub J, Bizino, Maurice B, van Veen, Suzanne, Vianello, Eleonora, Stienstra, Rinke, Ottenhoff, Tom H M, Lamb, Hildo J, Smit, Johannes W A, Jazet, Ingrid M, Rensen, Patrick C N, Boon, Mariëtte R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999357/
https://www.ncbi.nlm.nih.gov/pubmed/36262060
http://dx.doi.org/10.1210/clinem/dgac598
_version_ 1784903648190398464
author Straat, Maaike E
Martinez-Tellez, Borja
van Eyk, Huub J
Bizino, Maurice B
van Veen, Suzanne
Vianello, Eleonora
Stienstra, Rinke
Ottenhoff, Tom H M
Lamb, Hildo J
Smit, Johannes W A
Jazet, Ingrid M
Rensen, Patrick C N
Boon, Mariëtte R
author_facet Straat, Maaike E
Martinez-Tellez, Borja
van Eyk, Huub J
Bizino, Maurice B
van Veen, Suzanne
Vianello, Eleonora
Stienstra, Rinke
Ottenhoff, Tom H M
Lamb, Hildo J
Smit, Johannes W A
Jazet, Ingrid M
Rensen, Patrick C N
Boon, Mariëtte R
author_sort Straat, Maaike E
collection PubMed
description CONTEXT: South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. OBJECTIVE: This work aimed to study whether circulating messenger RNA (mRNA) transcripts of immune genes are different between South Asian compared with Europid patients with T2D. METHODS: A secondary analysis was conducted of 2 randomized controlled trials of Dutch South Asian (n = 45; age: 55 ± 10 years, body mass index [BMI]: 29 ± 4 kg/m(2)) and Dutch Europid (n = 44; age: 60 ± 7 years, BMI: 32 ± 4 kg/m(2)) patients with T2D. Main outcome measures included mRNA transcripts of 182 immune genes (microfluidic quantitative polymerase chain reaction; Fluidigm Inc) in fasted whole-blood, ingenuity pathway analyses (Qiagen). RESULTS: South Asians, compared to Europids, had higher mRNA levels of B-cell markers (CD19, CD79A, CD79B, CR2, CXCR5, IGHD, MS4A1, PAX5; all fold change > 1.3, false discovery rate [FDR] < 0.008) and interferon (IFN)-signaling genes (CD274, GBP1, GBP2, GBP5, FCGR1A/B/CP, IFI16, IFIT3, IFITM1, IFITM3, TAP1; all FC > 1.2, FDR < 0.05). In South Asians, the IFN signaling pathway was the top canonical pathway (z score 2.6; P < .001) and this was accompanied by higher plasma IFN-γ levels (FC = 1.5, FDR = 0.01). Notably, the ethnic difference in gene expression was larger for women (20/182 [11%]) than men (2/182 [1%]). CONCLUSION: South Asian patients with T2D show a more activated IFN-signaling pathway compared to Europid patients with T2D, which is more pronounced in women than men. We speculate that a more activated IFN-signaling pathway may contribute to the more rapid progression of T2D in South Asian compared with Europid individuals.
format Online
Article
Text
id pubmed-9999357
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99993572023-03-11 Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes Straat, Maaike E Martinez-Tellez, Borja van Eyk, Huub J Bizino, Maurice B van Veen, Suzanne Vianello, Eleonora Stienstra, Rinke Ottenhoff, Tom H M Lamb, Hildo J Smit, Johannes W A Jazet, Ingrid M Rensen, Patrick C N Boon, Mariëtte R J Clin Endocrinol Metab Clinical Research Article CONTEXT: South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. OBJECTIVE: This work aimed to study whether circulating messenger RNA (mRNA) transcripts of immune genes are different between South Asian compared with Europid patients with T2D. METHODS: A secondary analysis was conducted of 2 randomized controlled trials of Dutch South Asian (n = 45; age: 55 ± 10 years, body mass index [BMI]: 29 ± 4 kg/m(2)) and Dutch Europid (n = 44; age: 60 ± 7 years, BMI: 32 ± 4 kg/m(2)) patients with T2D. Main outcome measures included mRNA transcripts of 182 immune genes (microfluidic quantitative polymerase chain reaction; Fluidigm Inc) in fasted whole-blood, ingenuity pathway analyses (Qiagen). RESULTS: South Asians, compared to Europids, had higher mRNA levels of B-cell markers (CD19, CD79A, CD79B, CR2, CXCR5, IGHD, MS4A1, PAX5; all fold change > 1.3, false discovery rate [FDR] < 0.008) and interferon (IFN)-signaling genes (CD274, GBP1, GBP2, GBP5, FCGR1A/B/CP, IFI16, IFIT3, IFITM1, IFITM3, TAP1; all FC > 1.2, FDR < 0.05). In South Asians, the IFN signaling pathway was the top canonical pathway (z score 2.6; P < .001) and this was accompanied by higher plasma IFN-γ levels (FC = 1.5, FDR = 0.01). Notably, the ethnic difference in gene expression was larger for women (20/182 [11%]) than men (2/182 [1%]). CONCLUSION: South Asian patients with T2D show a more activated IFN-signaling pathway compared to Europid patients with T2D, which is more pronounced in women than men. We speculate that a more activated IFN-signaling pathway may contribute to the more rapid progression of T2D in South Asian compared with Europid individuals. Oxford University Press 2022-10-20 /pmc/articles/PMC9999357/ /pubmed/36262060 http://dx.doi.org/10.1210/clinem/dgac598 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research Article
Straat, Maaike E
Martinez-Tellez, Borja
van Eyk, Huub J
Bizino, Maurice B
van Veen, Suzanne
Vianello, Eleonora
Stienstra, Rinke
Ottenhoff, Tom H M
Lamb, Hildo J
Smit, Johannes W A
Jazet, Ingrid M
Rensen, Patrick C N
Boon, Mariëtte R
Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
title Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
title_full Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
title_fullStr Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
title_full_unstemmed Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
title_short Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
title_sort differences in inflammatory pathways between dutch south asians vs dutch europids with type 2 diabetes
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999357/
https://www.ncbi.nlm.nih.gov/pubmed/36262060
http://dx.doi.org/10.1210/clinem/dgac598
work_keys_str_mv AT straatmaaikee differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT martineztellezborja differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT vaneykhuubj differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT bizinomauriceb differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT vanveensuzanne differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT vianelloeleonora differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT stienstrarinke differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT ottenhofftomhm differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT lambhildoj differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT smitjohanneswa differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT jazetingridm differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT rensenpatrickcn differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes
AT boonmarietter differencesininflammatorypathwaysbetweendutchsouthasiansvsdutcheuropidswithtype2diabetes